Takeda Pharmaceutical
302 hedge funds and large institutions have $1.6B invested in Takeda Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
-12
Holders Change %
-3.82%
% of All Funds
5.27%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
29
Increased
93
Reduced
102
Closed
41
Calls
$58.8M
Puts
$28.6M
Net Calls
+$30.2M
Net Calls Change
+$24M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.2M |
| 2 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$12.7M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$11M |
| 4 |
Citigroup
New York
|
+$8.31M |
| 5 |
Barclays
London,
United Kingdom
|
+$7.83M |
Top Sellers
| 1 |
GCM
Glenview Capital Management
New York
|
-$118M |
| 2 |
PC
Paulson & Co
New York
|
-$86.3M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$54.3M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$21.1M |
| 5 |
Renaissance Technologies
New York
|
-$19.1M |
